Sleep Medicine Reviews
Volume 14, Issue 4 , Pages 269-280 , August 2010

The role of environmental light in sleep and health: Effects of ocular aging and cataract surgery

  • Patricia L. Turner

      Affiliations

    • Department of Ophthalmology, University of Kansas School of Medicine, 7400 State Line Road, Prairie Village, KS 66208-3444, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 913 345 0596; fax: +1 913 345 0597.
    • ,
  • Eus J.W. Van Someren

      Affiliations

    • Netherlands Institute for Neuroscience, an institute of the Royal Netherlands Academy of Arts and Sciences, Meibergdreef 47, 1105 BA Amsterdam, The Netherlands
    • Tel.: +31 20 5665500; fax: +31 20 6961006. e.van.someren@nin.knaw.nl.
    • ,
  • Martin A. Mainster

      Affiliations

    • Department of Ophthalmology, University of Kansas School of Medicine, 7400 State Line Road, Prairie Village, KS 66208-3444, USA
    • Tel.: +1 913 345 0596; fax: +1 913 345 0597. mmainste@kumc.edu.

Received 2 March 2009 ,Revised 6 November 2009 ,Accepted 6 November 2009.

References∗ 

  1. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295:1070–1073
  2. Hannibal J, Fahrenkrug J. Neuronal input pathways to the brain's biological clock and their functional significance. Adv Anat Embryol Cell Biol. 2006;182:1–71
  3. Berson DM. Strange vision: ganglion cells as circadian photoreceptors. Trends Neurosci. 2003;26:314–320
  4. Thapan K, Arendt J, Skene DJ. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol. 2001;535:261–267
  5. Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001;21:6405–6412
  6. Lockley SW, Evans EE, Scheer FA, Brainard GC, Czeisler CA, Aeschbach D. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep. 2006;29:161–168
  7. Mainster MA. Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol. 2006;90:784–792
  8. Cajochen C, Munch M, Kobialka S, Krauchi K, Steiner R, Oelhafen P, et al. High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab. 2005;90:1311–1316
  9. Vandewalle G, Gais S, Schabus M, Balteau E, Carrier J, Darsaud A, et al. Wavelength-Dependent Modulation of Brain Responses to a Working Memory Task by Daytime Light Exposure. Cereb Cortex. 2007;17:2788–2795
  10. Rea MS, Figueiro MG, Bullough JD, Bierman A. A model of phototransduction by the human circadian system. Brain Res Brain Res Rev. 2005;50:213–22810aMure LS, Rieux C, Hattar S, Cooper HM. Melanopsin-dependent nonvisual responses: evidence for photopigment bistability in vivo. J Biol Rhythms. 2007;22:411–424
  11. Turner PL, Mainster MA. Circadian photoreception: Aging and the eye's important role in systemic health. Br J Ophthalmol. 2008;92:1439–1444
  12. Lubkin V, Beizai P, Sadun AA. The eye as metronome of the body. Surv Ophthalmol. 2002;47:17–26
  13. Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma. 2004;113:103–112
  14. Czeisler CA, Klerman EB. Circadian and sleep-dependent regulation of hormone release in humans. Recent Prog Horm Res. 1999;54:97–130discussion 130–132
  15. Buijs RM, Scheer FA, Kreier F, Yi C, Bos N, Goncharuk VD, et al. Chapter 20: Organization of circadian functions: interaction with the body. Prog Brain Res. 2006;153:341–360
  16. Kalsbeek A, Ruiter M, La Fleur SE, Cailotto C, Kreier F, Buijs RM. Chapter 17: The hypothalamic clock and its control of glucose homeostasis. Prog Brain Res. 2006;153:283–307
  17. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002;360:1840–1842
  18. Lupien SJ, Nair NP, Briere S, Maheu F, Tu MT, Lemay M, et al. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci. 1999;10:117–139
  19. Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999;284:2177–2181
  20. Stratmann M, Schibler U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J Biol Rhythms. 2006;21:494–506
  21. Mistlberger RE. Circadian regulation of sleep in mammals: role of the suprachiasmatic nucleus. Brain Res Brain Res Rev. 2005;49:429–454
  22. Klerman EB. Clinical aspects of human circadian rhythms. J Biol Rhythms. 2005;20:375–386
  23. Van Someren EJ, Riemersma RF, Swaab DF. Functional plasticity of the circadian timing system in old age: light exposure. Prog Brain Res. 2002;138:205–231
  24. Hofman MA, Swaab DF. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev. 2006;5:33–51
  25. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4:649–661
  26. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell. 2004;119:693–705
  27. Monk TH, Buysse DJ, Billy BD, Kennedy KS, Kupfer DJ. The effects on human sleep and circadian rhythms of 17 days of continuous bedrest in the absence of daylight. Sleep. 1997;20:858–864
  28. Erren TC, Reiter RJ. A generalized theory of carcinogenesis due to chronodisruption. Neuro Endocrinol Lett. 2008;29:815–821
  29. Van Someren EJ, Riemersma-Van Der Lek RF. Live to the rhythm, slave to the rhythm. Sleep Med Rev. 2007;11:465–484
  30. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: Nature's most versatile biological signal?. Febs J. 2006;273:2813–2838
  31. Perreau-Lenz S, Kalsbeek A, Garidou ML, Wortel J, van der Vliet J, van Heijningen C, et al. Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms. Eur J Neurosci. 2003;17:221–228
  32. St Hilaire MA, Gronfier C, Zeitzer JM, Klerman EB. A physiologically based mathematical model of melatonin including ocular light suppression and interactions with the circadian pacemaker. J Pineal Res. 2007;43:294–304
  33. Czeisler CA. The effect of light on the human circadian pacemaker. Ciba Found Symp. 1995;183:254–290discussion 290–302
  34. Skene DJ, Lockley SW, Thapan K, Arendt J. Effects of light on human circadian rhythms. Reprod Nutr Dev. 1999;39:295–304
  35. Brainard GC, Hanifin JP, Rollag MD, Greeson J, Byrne B, Glickman G, et al. Human melatonin regulation is not mediated by the three cone photopic visual system. J Clin Endocrinol Metab. 2001;86:433–436
  36. Hu K, Van Someren EJ, Shea SA, Scheer FA. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker. Proc Natl Acad Sci U S A. 2009;
  37. Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, et al. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain. 2008;131:1609–1617
  38. Carvalho-Bos SS, Riemersma-van der Lek RF, Waterhouse J, Reilly T, Van Someren EJ. Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry. 2007;15:92–100
  39. Huang YL, Liu RY, Wang QS, Van Someren EJ, Xu H, Zhou JN. Age-associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav. 2002;76:597–603
  40. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J Pineal Res. 2007;42:28–42
  41. Benot S, Goberna R, Reiter RJ, Garcia-Maurino S, Osuna C, Guerrero JM. Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res. 1999;27:59–64
  42. Waldhauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M, Schemper M, et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab. 1988;66:648–652
  43. Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM. Human melatonin production decreases with age. J Pineal Res. 1986;3:379–388
  44. Zeitzer JM, Daniels JE, Duffy JF, Klerman EB, Shanahan TL, Dijk DJ, et al. Do plasma melatonin concentrations decline with age?. Am J Med. 1999;107:432–436
  45. Halberg F, Cornelissen G, Ulmer W, Blank M, Hrushesky W, Wood P, et al. Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers. J Exp Ther Oncol. 2006;6:73–84
  46. Mishima K, Tozawa T, Satoh K, Matsumoto Y, Hishikawa Y, Okawa M. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol Psychiatry. 1999;45:417–421
  47. Yaprak M, Altun A, Vardar A, Aktoz M, Ciftci S, Ozbay G. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int J Cardiol. 2003;89:103–107
  48. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005;97:1084–1087
  49. Robeva R, Kirilov G, Tomova A, Kumanov P. Melatonin-insulin interactions in patients with metabolic syndrome. J Pineal Res. 2008;44:52–56
  50. Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, et al. Neuroendocrine features in extreme longevity. Exp Gerontol. 2007;43:88–94
  51. Korkushko OV, Khavinson V, Shatilo VB, Magdich LV, Labunets IF. Circadian rhythms of pineal gland melatonin-forming function in healthy elderly people. Adv Gerontol. 2004;15:70–75
  52. Gallagher FW, Beasley WH, Gohren CF. Green thunderstorms observed. Bulletin of the American Meteorological Society. 1996;77:2889–2897
  53. Figueiro MG, Rea MS, Bullough JD. Does architectural lighting contribute to breast cancer?. J Carcinog. 2006;5:20
  54. Lynch HJ, Deng MH, Wurtman RJ. Indirect effects of light: ecological and ethological considerations. Ann N Y Acad Sci. 1985;453:231–241
  55. Lack LC, Wright HR. Shorter wavelength light is more effective for changing melatonin phase. Chronobiol Int. 2003;20:1179–1181
  56. Mishima K, Okawa M, Shimizu T, Hishikawa Y. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metab. 2001;86:129–134
  57. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162:656–662
  58. Lee TM, Chan CC, Paterson JG, Janzen HL, Blashko CA. Spectral properties of phototherapy for seasonal affective disorder: a meta-analysis. Acta Psychiatr Scand. 1997;96:117–121
  59. Mills PR, Tomkins SC, Schlangen LJ. The effect of high correlated colour temperature office lighting on employee wellbeing and work performance. J Circadian Rhythms. 2007;5:2
  60. Partonen T, Lonnqvist J. Bright light improves vitality and alleviates distress in healthy people. J Affect Disord. 2000;57:55–61
  61. Meijer JH, Watanabe K, Schaap J, Albus H, Detari L. Light responsiveness of the suprachiasmatic nucleus: long-term multiunit and single-unit recordings in freely moving rats. J Neurosci. 1998;18:9078–9087
  62. Mutoh T, Shibata S, Korf HW, Okamura H. Melatonin modulates the light-induced sympathoexcitation and vagal suppression with participation of the suprachiasmatic nucleus in mice. J Physiol. 2003;547:317–332
  63. Lucassen PJ, Hofman MA, Swaab DF. Increased light intensity prevents the age related loss of vasopressin-expressing neurons in the rat suprachiasmatic nucleus. Brain Res. 1995;693:261–266
  64. Dijk DJ, Neri DF, Wyatt JK, Ronda JM, Riel E, Ritz-De Cecco A, et al. Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1647–R1664
  65. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab. 1997;82:3763–3770
  66. Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med. 1995;332:6–11
  67. Lockley SW, Skene DJ, Tabandeh H, Bird AC, Defrance R, Arendt J. Relationship between napping and melatonin in the blind. J Biol Rhythms. 1997;12:16–25
  68. Miles LE, Raynal DM, Wilson MA. Blind man living in normal society has circadian rhythms of 24.9 hours. Science. 1977;198:421–423
  69. Lewy AJ, Emens JS, Lefler BJ, Yuhas K, Jackman AR. Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int. 2005;22:1093–1106
  70. Lewy AJ, Bauer VK, Hasler BP, Kendall AR, Pires ML, Sack RL. Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res. 2001;918:96–100
  71. Knudtson MD, Klein BE, Klein R. Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. Arch Ophthalmol. 2006;124:243–249
  72. Lee DJ, Gomez-Marin O, Lam BL, Zheng DD. Glaucoma and survival: the National Health Interview Survey 1986-1994. Ophthalmology. 2003;110:1476–1483
  73. McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts 5 year mortality. Br J Ophthalmol. 2001;85:322–326
  74. West SK, Munoz B, Istre J, Rubin GS, Friedman SM, Fried LP, et al. Mixed lens opacities and subsequent mortality. Arch Ophthalmol. 2000;118:393–397
  75. Foong AW, Fong CW, Wong TY, Saw SM, Heng D, Foster PJ. Visual acuity and mortality in a chinese population. The Tanjong Pagar Study. Ophthalmology. 2008;115:802–807
  76. Fischer S, Smolnik R, Herms M, Born J, Fehm HL. Melatonin acutely improves the neuroendocrine architecture of sleep in blind individuals. J Clin Endocrinol Metab. 2003;88:5315–5320
  77. Van Someren EJ, Scherder EJ, Swaab DF. Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12:114–118
  78. Scherder EJ, Van Someren EJ, Swaab DF. Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer's disease. Behav Brain Res. 1999;101:105–107
  79. Sletten TL, Revell VL, Middleton B, Lederle KA, Skene DJ. Age-related changes in acute and phase-advancing responses to monochromatic light. J Biol Rhythms. 2009;24:73–84
  80. Scheer FA, Buijs RM. Light affects morning salivary cortisol in humans. J Clin Endocrinol Metab. 1999;84:3395–3398
  81. Barker FM, Brainard GC. The Direct Spectral Transmittance of the Excised Human Lens as a Function of Age, (FDA 785345 0090 RA). Washington, DC.: U.S. Food and Drug Administration; 1991;
  82. Yang Y, Thompson K, Burns SA. Pupil location under mesopic, photopic, and pharmacologically dilated conditions. Invest Ophthalmol Vis Sci. 2002;43:2508–2512
  83. Charman WN. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol Opt. 2003;23:181–187
  84. Harman A, Abrahams B, Moore S, Hoskins R. Neuronal density in the human retinal ganglion cell layer from 16-77 years. Anat Rec. 2000;260:124–131
  85. Curcio CA, Owsley C, Jackson GR. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41:2015–2018
  86. Li RS, Chen BY, Tay DK, Chan HH, Pu ML, So KF. Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. Invest Ophthalmol Vis Sci. 2006;47:2951–2958
  87. Knight JA, Thompson S, Raboud JM, Hoffman BR. Light and exercise and melatonin production in women. Am J Epidemiol. 2005;162:1114–1122
  88. Lee H-C. Introduction to Color Imaging Science. Cambridge: Cambridge University Press; 2005;
  89. Pears A. Strategic Study of Household Energy and Greenhouse Issues. In:  Australia E editors. Australian Greenhouse Office. 1998;p. 61–63
  90. Ryer AD. The light measurement handbook. Newburyport, MA: International Light, Inc.; 1997;
  91. Dawson D, Campbell SS. Bright light treatment: are we keeping our subjects in the dark?. Sleep. 1990;13:267–271
  92. Gaddy JR, Rollag MD, Brainard GC. Pupil size regulation of threshold of light-induced melatonin suppression. J Clin Endocrinol Metab. 1993;77:1398–1401
  93. Gronfier C, Wright KP, Kronauer RE, Czeisler CA. Entrainment of the human circadian pacemaker to longer-than-24-h days. Proc Natl Acad Sci U S A. 2007;104:9081–9086
  94. Middleton B, Stone BM, Arendt J. Human circadian phase in 12:12 h, 200: <8 lux and 1000: <8 lux light-dark cycles, without scheduled sleep or activity. Neurosci Lett. 2002;329:41–44
  95. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Quantal melatonin suppression by exposure to low intensity light in man. Life Sci. 1989;45:327–332
  96. Nilssen O, Lipton R, Brenn T, Hoyer G, Boiko E, Tkatchev A. Sleeping problems at 78 degrees north: the Svalbard Study. Acta Psychiatr Scand. 1997;95:44–48
  97. Husby R, Lingjaerde O. Prevalence of reported sleeplessness in northern Norway in relation to sex, age and season. Acta Psychiatr Scand. 1990;81:542–547
  98. Oren DA, Giesen HA, Wehr TA. Restoration of detectable melatonin after entrainment to a 24-hour schedule in a 'free-running' man. Psychoneuroendocrinology. 1997;22:39–52
  99. Bloch KE, Brack T, Wirz-Justice A. Transient short free running circadian rhythm in a case of aneurysm near the suprachiasmatic nuclei. J Neurol Neurosurg Psychiatry. 2005;76:1178–1180
  100. Jean-Louis G, Kripke D, Cohen C, Zizi F, Wolintz A. Associations of ambient illumination with mood: contribution of ophthalmic dysfunctions. Physiol Behav. 2005;84:479–487
  101. Spoont MR, Depue RA, Krauss SS. Dimensional measurement of seasonal variation in mood and behavior. Psychiatry Res. 1991;39:269–284
  102. Harmatz MG, Well AD, Overtree CE, Kawamura KY, Rosal M, Ockene IS. Seasonal variation of depression and other moods: a longitudinal approach. J Biol Rhythms. 2000;15:344–350
  103. Dam H, Jakobsen K, Mellerup E. Prevalence of winter depression in Denmark. Acta Psychiatr Scand. 1998;97:1–4
  104. Miller AL. Epidemiology, etiology, and natural treatment of seasonal affective disorder. Altern Med Rev. 2005;10:5–13
  105. Espiritu RC, Kripke DF, Ancoli-Israel S, Mowen MA, Mason WJ, Fell RL, et al. Low illumination experienced by San Diego adults: association with atypical depressive symptoms. Biol Psychiatry. 1994;35:403–407
  106. Haynes PL, Ancoli-Israel S, McQuaid J. Illuminating the impact of habitual behaviors in depression. Chronobiol Int. 2005;22:279–297
  107. Otsuka K, Yamanaka G, Shinagawa M, Murakami S, Yamanaka T, Shibata K, et al. Chronomic community screening reveals about 31% depression, elevated blood pressure and infradian vascular rhythm alteration. Biomed Pharmacother. 2004;58(Suppl. 1):S48–S55
  108. Yaffe K, Edwards ER, Covinsky KE, Lui LY, Eng C. Depressive symptoms and risk of mortality in frail, community-living elderly persons. Am J Geriatr Psychiatry. 2003;11:561–567
  109. Savides TJ, Messin S, Senger C, Kripke DF. Natural light exposure of young adults. Physiol Behav. 1986;38:571–574
  110. Hebert M, Dumont M, Paquet J. Seasonal and diurnal patterns of human illumination under natural conditions. Chronobiol Int. 1998;15:59–70
  111. Campbell SS, Kripke DF, Gillin JC, Hrubovcak JC. Exposure to light in healthy elderly subjects and Alzheimer's patients. Physiol Behav. 1988;42:141–144
  112. Duncan DD, Munoz B, West SK. Assessment of ocular exposure to visible light for population studies. Dev Ophthalmol. 2002;35:76–92
  113. Ancoli-Israel S, Klauber MR, Jones DW, Kripke DF, Martin J, Mason W, et al. Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients. Sleep. 1997;20:18–23
  114. Shochat T, Martin J, Marler M, Ancoli-Israel S. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res. 2000;9:373–379
  115. Roenneberg T, Aschoff J. Annual rhythm of human reproduction: II. Environmental correlations. J Biol Rhythms. 1990;5:217–239
  116. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005;27:179–188
  117. Erren TC, Pape HG, Reiter RJ, Piekarski C. Chronodisruption and cancer. Naturwissenschaften. 2008;95:367–382
  118. Stevens RG, Davis S. The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect. 1996;104(Suppl. 1):135–140
  119. Herljevic M, Middleton B, Thapan K, Skene DJ. Light-induced melatonin suppression: age-related reduction in response to short wavelength light. Exp Gerontol. 2005;40:237–242
  120. Folkard S. Do permanent night workers show circadian adjustment? A review based on the endogenous melatonin rhythm. Chronobiol Int. 2008;25:215–224
  121. Knutsson A. Health disorders of shift workers. Occup Med (Lond). 2003;53:103–108
  122. Rouch I, Wild P, Ansiau D, Marquie JC. Shiftwork experience, age and cognitive performance. Ergonomics. 2005;48:1282–1293
  123. Cho K. Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits. Nat Neurosci. 2001;4:567–568
  124. Menezes MC, Pires ML, Benedito-Silva AA, Tufik S. Sleep parameters among offshore workers: an initial assessment in the Campos Basin, Rio De Janeiro, Brazil. Chronobiol Int. 2004;21:889–897
  125. Knutsson A, Hammar N, Karlsson B. Shift workers' mortality scrutinized. Chronobiol Int. 2004;21:1049–1053
  126. Hahn RA. Profound bilateral blindness and the incidence of breast cancer. Epidemiology. 1991;2:208–210
  127. Feychting M, Osterlund B, Ahlbom A. Reduced cancer incidence among the blind. Epidemiology. 1998;9:490–494
  128. Pukkala E, Ojamo M, Rudanko SL, Stevens RG, Verkasalo PK. Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment. Cancer Causes Control. 2006;17:573–576
  129. Rogot E, Goldberg ID, Goldstein H. Survivorship and causes of death among the blind. J Chronic Dis. 1966;19:179–197
  130. Asplund R, Ejdervik Lindblad B. The development of sleep in persons undergoing cataract surgery. Arch Gerontol Geriatr. 2002;35:179–187
  131. Leger D, Guilleminault C, Defrance R, Domont A, Paillard M. Prevalence of sleep/wake disorders in persons with blindness. Clin Sci (Lond). 1999;97:193–199
  132. Kellner M, Yassouridis A, Manz B, Steiger A, Holsboer F, Wiedemann K. Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers–a potential link to low-melatonin syndrome in depression?. Neuroendocrinology. 1997;65:284–290
  133. Liu RY, Unmehopa UA, Zhou JN, Swaab DF. Glucocorticoids suppress vasopressin gene expression in human suprachiasmatic nucleus. J Steroid Biochem Mol Biol. 2006;98:248–253
  134. Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab. 1998;83:1573–1579
  135. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86:3787–3794
  136. Rodenbeck A, Hajak G. Neuroendocrine dysregulation in primary insomnia. Rev Neurol (Paris). 2001;157:S57–S61
  137. Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry. 2005;20(Suppl. 3):S302–S306
  138. Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, et al. Do corticosteroids damage the brain?. J Neuroendocrinol. 2006;18:393–411
  139. Wirtz PH, von Kanel R, Emini L, Ruedisueli K, Groessbauer S, Maercker A, et al. Evidence for altered hypothalamus-pituitary-adrenal axis functioning in systemic hypertension: Blunted cortisol response to awakening and lower negative feedback sensitivity. Psychoneuroendocrinology. 2007;32:430–436
  140. Singh RB, Kartik C, Otsuka K, Pella D, Pella J. Brain-heart connection and the risk of heart attack. Biomed Pharmacother. 2002;56(Suppl. 2):257s–265s
  141. Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag. 2005;1:291–299
  142. Van Cauter E, Plat L, Leproult R, Copinschi G. Alterations of circadian rhythmicity and sleep in aging: endocrine consequences. Horm Res. 1998;49:147–152
  143. Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metabolism. 2002;51:5–10
  144. Zhou JN, Liu RY, van Heerikhuize J, Hofman MA, Swaab DF. Alterations in the circadian rhythm of salivary melatonin begin during middle-age. J Pineal Res. 2003;34:11–16
  145. Schernhammer ES, Hankinson SE. Urinary melatonin levels and postmenopausal breast cancer risk in the nurses' health study cohort. Cancer Epidemiol Biomarkers Prev. 2009;18:74–79
  146. Danilenko KV, Plisov IL, Wirz-Justice A, Hebert M. Human retinal light sensitivity and melatonin rhythms following four days in near darkness. Chronobiol Int. 2009;26:93–107
  147. Asplund R, Henriksson S, Johansson S, Isacsson G. Nocturia and depression. BJU Int. 2004;93:1253–1256
  148. Ancoli-Israel S, Cooke JR. Prevalence and comorbidity of insomnia and effect on functioning in elderly populations. J Am Geriatr Soc. 2005;53:S264–S271
  149. Kobayashi R, Kohsaka M, Fukuda N, Sakakibara S, Honma H, Koyama T. Effects of morning bright light on sleep in healthy elderly women. Psychiatry Clin Neurosci. 1999;53:237–238
  150. Hood B, Bruck D, Kennedy G. Determinants of sleep quality in the healthy aged: the role of physical, psychological, circadian and naturalistic light variables. Age Ageing. 2004;33:159–165
  151. Campbell SS, Dawson D, Anderson MW. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc. 1993;41:829–836
  152. Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA. 2008;299:2642–2655
  153. Fetveit A, Skjerve A, Bjorvatn B. Bright light treatment improves sleep in institutionalised elderly–an open trial. Int J Geriatr Psychiatry. 2003;18:520–526
  154. Asplund R, Lindblad BE. Sleep and sleepiness 1 and 9 months after cataract surgery. Arch Gerontol Geriatr. 2004;38:69–75
  155. Kohsaka M, Kohsaka S, Fukuda N, Honma H, Sakakibara S, Kawai I, et al. Effects of bright light exposure on heart rate variability during sleep in young women. Psychiatry Clin Neurosci. 2001;55:283–284155aBonnet MH, Arand DL. Hyperarousal and insomnia: State of the science (epub). Sleep Med Rev. 2009;
  156. Steriade M. Slow-wave sleep: serotonin, neuronal plasticity, and seizures. Arch Ital Biol. 2004;142:359–367
  157. Vgontzas AN, Chrousos GP. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am. 2002;31:15–36
  158. Grandner MA, Kripke DF, Langer RD. Light exposure is related to social and emotional functioning and to quality of life in older women. Psychiatry Res. 2006;143:35–42
  159. Rao ML, Muller-Oerlinghausen B, Mackert A, Strebel B, Stieglitz RD, Volz HP. Blood serotonin, serum melatonin and light therapy in healthy subjects and in patients with nonseasonal depression. Acta Psychiatr Scand. 1992;86:127–132
  160. Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology. 1999;21:46S–51S
  161. Koller G, Bondy B, Preuss UW, Zill P, Soyka M. The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients. Behav Brain Funct. 2006;2:7
  162. Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry. 2006;59:502–507
  163. McEnany GW, Lee KA. Effects of light therapy on sleep, mood, and temperature in women with nonseasonal major depression. Issues Ment Health Nurs. 2005;26:781–794
  164. Park SJ, Tokura H. Bright light exposure during the daytime affects circadian rhythms of urinary melatonin and salivary immunoglobulin A. Chronobiol Int. 1999;16:359–371
  165. Hashimoto S, Kohsaka M, Nakamura K, Honma H, Honma S, Honma K. Midday exposure to bright light changes the circadian organization of plasma melatonin rhythm in humans. Neurosci Lett. 1997;221:89–92
  166. Kanikowska D, Hirata Y, Hyun K, Tokura H. Acute phase proteins, body temperature and urinary melatonin under the influence of bright and dim light intensities during the daytime. J Physiol Anthropol Appl Human Sci. 2001;20:333–338
  167. Wakamura T, Tokura H. Influence of bright light during daytime on sleep parameters in hospitalized elderly patients. J Physiol Anthropol Appl Human Sci. 2001;20:345–351
  168. Nicklas MH, Bailey GB. Analysis of the Performance of Students of Daylit Schools. Washington, D.C.: Education Resources Information Center, U.S. Department of Education; 1996;
  169. Edwards L, Torcellini P. A Literature Review of the Effects of Natural Light on Building Occupants. Golden, Colorado: National Renewable Energy Laboratory. U.S. Department of Energy. 2002;
  170. Keep PJ. Stimulus deprivation in windowless rooms. Anaesthesia. 1977;32:598–602
  171. Yamadera H, Ito T, Suzuki H, Asayama K, Ito R, Endo S. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci. 2000;54:352–353
  172. Van Der Werf YD, Altena E, Schoonheim MM, Sanz-Arigita EJ, Vis JC, De Rijke W, et al. Sleep benefits subsequent hippocampal functioning. Nat Neurosci. 2009;12:122–123
  173. Okawa M, Mishima K, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep. 1991;14:478–485
  174. Martin JL, Webber AP, Alam T, Harker JO, Josephson KR, Alessi CA. Daytime sleeping, sleep disturbance, and circadian rhythms in the nursing home. Am J Geriatr Psychiatry. 2006;14:121–129
  175. Jacobs D, Ancoli-Israel S, Parker L, Kripke DF. Twenty-four-hour sleep-wake patterns in a nursing home population. Psychol Aging. 1989;4:352–356
  176. Gonzalez MM, Aston-Jones G. Circadian regulation of arousal: role of the noradrenergic locus coeruleus system and light exposure. Sleep. 2006;29:1327–1336
  177. Lovell BB, Ancoli-Israel S, Gevirtz R. Effect of bright light treatment on agitated behavior in institutionalized elderly subjects. Psychiatry Res. 1995;57:7–12
  178. Fontana Gasio P, Krauchi K, Cajochen C, Someren E, Amrhein I, Pache M, et al. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp Gerontol. 2003;38:207–216
  179. Mainster MA. The spectra, classification, and rationale of ultraviolet-protective intraocular lenses. Am J Ophthalmol. 1986;102:727–732
  180. Mainster MA, Turner PL. Blue-blocking IOLs Decrease Photoreception without Providing Significant Photoprotection (epub). Surv Ophthalmol. 2009;
  181. Chew EY, Sperduto RD, Milton RC, Clemons TE, Gensler GR, Bressler SB, et al. Risk of Advanced Age-Related Macular Degeneration after Cataract Surgery in the Age-Related Eye Disease Study AREDS Report 25. Ophthalmology. 2009;116:297–303
  182. Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol. 1995;119:202–210
  183. Mainster MA, Turner PL. Retinal injuries from light: mechanisms, hazards and prevention, Chapter 109. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson P, eds. Retina, 4th Edition. 2 vol. 4th ed. London: Elsevier Publishers; 2006:1857–1870.
  184. Mainster MA, Boulton M. Retinal phototoxicity, Chapter 174. In:  Albert DM,  Miller JW,  Blodi BA,  Azar DT editor. Principles and Practice of Ophthalmology. 3rd ed. London, UK: Elsevier; 2008;p. 2195–2205
  185. Mainster MA, Ham WT, Delori FC. Potential retinal hazards. Instrument and environmental light sources. Ophthalmology. 1983;90:927–932
  186. McCarty CA, Taylor HR. A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol. 2002;35:21–31
  187. Brainard GC, Rollag MD, Hanifin JP. Photic regulation of melatonin in humans: ocular and neural signal transduction. J Biol Rhythms. 1997;12:537–546
  188. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295:1065–1070
  189. Bullough JD, Rea MS, Figueiro MG. Of mice and women: light as a circadian stimulus in breast cancer research. Cancer Causes Control. 2006;17:375–383
  190. Hankins MW, Peirson SN, Foster RG. Melanopsin: an exciting photopigment. Trends Neurosci. 2008;31:27–36
  191. Lockley SW, Brainard GC, Czeisler CA. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab. 2003;88:4502–4505

PII: S1087-0792(09)00123-3

doi: 10.1016/j.smrv.2009.11.002

Sleep Medicine Reviews
Volume 14, Issue 4 , Pages 269-280 , August 2010

Article Tools

* Image Usage & Resolution